DON'T WORRY----NOBODY LIKES HER-----WE DON'T CARE ABOUT HER.
Again, I was 'USED' as victim of illegal surveillance video and PORN------but so were millions tens of millions and possibly hundreds of millions of US 99% WE THE PEOPLE. Anyone having these IMPLANTS these few decades were being used as experimental VICTIMS.
I was IMPLANTED with BLADDER---URETER/COLON IMPLANT I think either 2007 when I was KNOCKED OUT---at SINAI HOSPITAL under the pretense of PSYCHIATRIC problems which not exist----or during 2010 LEG injury at MED STAR. Either way-----these implants for BLADDER AND COLON were installed I will assume 2010 as starting point.
'Page 1 of 27 Medical Coverage Policy:0404 Medical Coverage Policy
EffectiveDate............................................10/15/2019Next Review Date ......................................10/15/2020
Coverage Policy Number .................................. 0404
Sacral Nerve and Tibial Nerve Stimulation for Urinary Voiding Dysfunction, Fecal Incontinence and Constipation'
'Sacral Nerve Stimulation - procedure, test, tube, pain ...
Sacral nerve stimulation, also known as sacral neuromodulation, is a procedure in which the sacral nerve at the base of the spine is stimulated by a mild electrical current from an implanted device. It is done to improve functioning of the urinary tract, to relieve pain related to urination, and to control fecal incontinence. '
I started having symptoms of CONSTIPATION------very long-term and brutal---I could not VOID my bowels. At the same time I started urinating more frequently and could never VOID MY BLADDER----ergo, I would urinate and feel I constantly needed to urinate again and again.
FEEDBACK FROM HOSTING SERVER NOSY NEIGHBORS SAID----SHE HAS BLADDER INCONTINENCE------SHE HAS BOWEL RESTRICTIONS WE NEED TO TREAT HER.
Another FEEDBACK from HOSTING SERVER NOSY NEIGHBORS was -------WE ARE GOING TO GIVE THEM HEMORRHOIDS----they will have to come in to be TREATED for these BODY MALFUNCTIONS.
NOSY NEIGHBORS laughing about giving me incontinence------and about creating a condition of hemorrhoids
those several years after 2010 IMPLANT ----NO CONSENT ---NO KNOWLEDGE------this was done knowing it would do DAMAGE.
Remember, I went into MED STAR with a BROKEN LEG-----below we see TIBIAL NERVE stimulation-------this implant on the lower back near PELVIS was installed pretending it had something to do with MY LEG INJURY.
I am THINKING about these PRODUCT DEVICES as they went through DEVELOPMENT. In 2007----2010 those devices had different physical components---differing battery components------I would likely have been the next cohort after this article below was written in 2009.
Your central source for Weizmann science stories
Advancing women in science
Accessibility at Weizmann
The physical and digital campus, available to all
Schwartz/Reisman Science Education Center, Rehovot
A hub for physics education on Ruth and Uriel Arnon Campus'
These are global banking 1% FAKE MEDICAL DATA FAKE NEWS media outlet trying to sell these IMPLANT DEVICES as social benefit when the goals are BODY/MIND CONTROL.
from research organizations
Electrical Implant Might Help With Bladder Control
April 16, 2009
Center for Advancing Health
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new review.
Hmmmm, how did that person become urinary incontinent?
For people with urinary incontinence who have run out of options, an electrical device might help, according to a new Cochrane Library review.
The battery-operated implant works with two small electrodes placed beneath the skin, near the sacrum or “tailbone,” to give a continuous shock to the nerves that control the bladder, causing the person to feel an uninterrupted tapping sensation in the pelvic area.
“There are few treatments that can claim to cure people with overactive bladders or urinary retention,” said lead author G. Peter Herbison, from the Dunedin School of Medicine in New Zealand. “It is possible that implanted pulse generators will do just that.”
“Depending on how it is defined, around 17 million people in the U.S. may have bladder control problems,” said Kenneth Peters, M.D., chairman of urology at Beaumont Hospital in Royal Oak, Mich.
Some people respond to medications, behavioral therapy or other noninvasive means, while surgery is useful mostly for those with stress incontinence.
Herbison and his co-author wanted to determine the effects that this type of device had in people with urine storage and voiding problems. They reviewed eight published studies involving 500 patients who had not responded to other less invasive treatments.
Most of the studies did not indicate whether participants were men or women. The reviewers deemed study quality either poor or difficult to assess; therefore, they did not combine the data for a pooled analysis. The reviewers also said that most of the longer-term studies have a poor rate of follow-up, which means there are questions about their reliability.
Overall, the results showed benefits primarily for patients with symptoms of overactive bladder and with no known obstruction who had failed other methods of treatment.
The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.
“For those who have tried all nonsurgical approaches – including bladder retraining, physiotherapy for the pelvic floor muscles and medications – yet the symptoms persist, it is worth discussing this option with your primary care doctor, who may refer you on to a urologist,” said review co-author Dr. Edwin Arnold, at the department of urology at Christchurch Hospital, in New Zealand. “This treatment is not for everyone and even if the operation is undertaken, it does not always work, so a patient’s expectations should remain realistic.”
Up to 30 percent of those who are evaluated for the implant are not good candidates and do not receive an implant, reviewers say. Of those who get the implants, another 30 percent might not see any benefit or find that the implants lose usefulness over time.
Those who would benefit from the procedure fall into two groups.
“Patients who might be considered are those in whom all nonsurgical approaches have been tried and whose symptoms remain bothersome and persistent,” Arnold said. “This includes those who have increased daytime frequency of passing urine, who need to rise at night to empty the bladder and associated urgency with or without urge incontinence.”
The second group of patients is relatively uncommon: those who are unable to empty the bladder yet have no mechanical obstruction.
Peters, who had no affiliation with the review, said that the results show there are other effective alternatives to help improve a person’s quality of life and manage their voiding complaints.
“This report supports the technology of neurostimulation, which has been literally life changing for many of my patients,” Peters said. “There is now very solid evidence that the procedure is useful, safe, reversible and should be an option in the treatment of more patients with these concerns.”
The review also helps to identify those who would benefit from the therapy, according to Stanley Zaslau, associate professor in the department of urology at West Virginia University, in Morgantown.
“Sacral neuromodulation has shown long-term effectiveness in treating voiding dysfunction,” Zaslau said. “This device should be considered by those who have failed other therapies but are motivated to achieve a cure in their disease.”
Hmmmm, I am waiting to see if going going gone battery death will allow MY sphincter to REPAIR from the effects of SACRAL NEUROMODULATION.
Manufacturers of these implants supported at least two of the reviewed studies, the review disclosed.
When I create a TIMELINE for my LAWSUIT against HOSTING SERVER AND NOSY NEIGHBORS AND GANG------the batteries in this TAILBONE IMPLANT have likely GONE WITH THE WIND. Any recent problems with bladder is likely me drinking too much TEA AND COFFEE.
My feeling is this: These IMPLANTS from 2010 with batteries did indeed create physical symptoms ------mostly NEGATIVE--BAD-----SENDING ME TO SPEND MONEY ON MEDICAL PRODUCTS------what I experienced after 2015--2016 when batteries were low or gone---was black market illegal streaming video PORN -----selling that video to DARK WEB PORN SITES to keep MONEY FLOWING.
Today, HOSTING SERVER NOSY NEIGHBORS are trying hard to KNOCK ME OUT----so they can UPDATE BATTERIES AND DEVICE PRODUCTS.
Hypothyroidism: Boost Your Wellness
8 Tips to Relieve Hypothyroidism-Related Constipation
Hypothyroidism treatment, fluids, and plenty of fiber can help alleviate this uncomfortable symptom.
By Madeline R. Vann, MPH Medically Reviewed by Farrokh Sohrabi, MD
Low thyroid hormone, or hypothyroidism, has many effects on your health, including your bowel movements. Constipation, in fact, is one of the most common symptoms of hypothyroidism, along with dry skin, sensitivity to cold, hair loss, difficulty concentrating, and fatigue, according to the American Association of Clinical Endocrinologists (AACE).
Constipation is defined by having three or fewer bowel movements a week, or by bowel movements that are painful and unproductive, according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Relieving constipation starts by treating your hypothyroidism but also involves making a few key lifestyle changes.
Hypothyroidism and Constipation
Having hypothyroidism means your thyroid hormone levels are low. Because your thyroid plays a role in helping manage your bodily processes, systems throughout your body might slow down when these levels are low, according to the AACE.
Digestion and passing stool are among the processes that can be affected by low thyroid hormone levels.
It’s important to talk to your doctor about both your thyroid and your constipation to make sure you’re taking the best steps to manage both.
“There are multiple different causes of constipation, so not everyone who has constipation can attribute the constipation to hypothyroidism,” says Jacqueline Jonklaas, MD, an associate professor of endocrinology and metabolism at Georgetown University in Washington, D.C. “Other causes of constipation may include side effects of drugs, dehydration, blockages in the gastrointestinal system, problems in the nerves controlling the gastrointestinal system, and diabetes.”
Constipation can also become more common as you age, even with normal thyroid hormone levels, she adds.
Still, Dr. Jonklaas explains, hypothyroidism can increase your risk of constipation.
How to Relieve Constipation
You don’t have to accept constipation as part of your hypothyroidism. Strategies you can use to get relief include:
Treat hypothyroidism. “If someone with hypothyroidism has constipation, it should be treated by treating the underlying hypothyroidism,” Jonklaas says. The AACE says treatment typically involves taking replacement hormone once a day by mouth. Stay in touch with your doctor so you can work together to narrow down the correct dosage for you. If constipation continues after a few months of hypothyroidism treatment and lifestyle changes to combat constipation, then you might need to talk to a gastroenterologist about other causes, she notes.
Review your medications.
The American Gastroenterological Medical Association (AGMA) recommends talking to your doctor or pharmacist about all the over-the-counter and prescription medications and supplements you’re taking to find out whether one or more of them might be contributing to constipation. You might need to stop taking medications that contribute to constipation or switch to something else.
Drink more water. Making sure you’re adequately hydrated is part of addressing constipation, Jonklaas says. Aim to drink 6 to 8 glasses of water a day. Getting enough fluids is particularly important if you’re going to be using fiber supplements.
Eat more fiber. National recommendations call for adult women to get at least 28 grams of fiber daily in their diet, while men should aim for 30 grams, according to the U.S. Department of Agriculture. Eating more fiber-rich foods — such as fruits with skin on, vegetables, berries, beans, and whole grains — could help with constipation. You may have heard that specific groups of vegetables, such as broccoli and kale, could increase your risk of a low-functioning thyroid, but that’s a controversial issue that’s still being studied, according to the AACE. Best advice? Talk to your doctor or a dietitian to develop a meal plan that works for you. Increase fiber in your diet gradually over several days or weeks until you reach your daily goal. Fiber supplements, such as those containing psyllium seed husks, may also help manage constipation, according to the AGMA.
Get more exercise. Aim for at least 150 minutes of moderate physical activity each week, which is the national recommendation for exercise. Increasing physical activity should be part of constipation management, according to a review of constipation treatment strategies published in the February 2017 issue of the Handbook of Experimental Pharmacology.
Consider a laxative. You can get over-the-counter oral laxatives that are inexpensive and generally safe, such as milk of magnesia, which is recommended by the AGMA. You can also try suppositories. If you’re not sure whether or how to use laxatives, talk to your doctor about what would be best in your situation.
Try bowel retraining. This is a strategy to help you gain control of your bowel movements. You might need to relearn your bathroom habits or establish a regular schedule for having a bowel movement. Avoid holding in a bowel movement when you need to produce one or straining to have a bowel movement when you do not feel the need to go. The NIDDK recommends talking to your doctor about techniques for bowel retraining to help your body have bowel movements at more regular times of the day.
Consider biofeedback. The guidelines for constipation management developed by AGMA say biofeedback -- a type of therapy that can be used to help people learn to relax their pelvic floor muscles — can improve your bowel habits.
Constipation may be a common symptom of hypothyroidism, but it’s also one you can proactively manage, even as you and your doctor work on improving your thyroid hormone levels.
The article below is long and complex medical study but please glance through to become familiar with TERMS and SYMPTOMS and remember the SOCIAL BENFIT given for this research is almost NEVER the goal.
We use the ANALOGY-----OF MASH-------the doctors during wartime VIETNAM. COLONEL POTTER was OLD-SCHOOL PHYSICIAN leading a crack team of MASH doctors and nurses. COLONEL POTTER recognized TRAPPER JOHN AND HAWKEYE as the best of his DOCTORS----THEY WERE PHYSICIANS/SURGEONS.
COLONEL POTTER saw MAJOR FRED BURNS as someone to KEEP OUT OF THE MEDICAL THEATER.
The ability to recognise REAL TALENT IN PHYSICIANS has disappeared these few decades of CLINTON/BUSH/OBAMA. We have watch our TRAPPER JOHNS----our HAWKEYES-----and leaders like COLONEL POTTER be replaced by MAJOR BURNS----
MAJOR BURNS was a BARBER SURGEON-----he could care less about the people coming through whether US soldier or local Asian casualties---he was painted as only interested in SOCIAL STATUS----IN FUTURE MONEY-MAKING------someone who would not be actively PRACTICING MEDICINE.
Today, we have allowed FRANK BURNS to be in charge of NATIONAL MEDICAL RESEARCH---to be in charge of our STATE AND LOCAL MEDICAL LEADERSHIP------
When our US 99% WE THE PEOPLE black, white, or brown READ these FAKE NEWS FAKE DATA MEDICAL RESEARCH articles they need to know ----almost all of this is propaganda hiding an AGENDA of MOVING FORWARD ONE WORLD 99% OF WE THE PEOPLE accessing ordinary health care through TELEMEDICINE ONLY.
Sacral Nerve Stimulation
Sacral neuromodulation is a long-term electrical stimulation of the S3 nerve root that has been approved by the FDA for the treatment of IDO, frequency-urgency syndrome, and idiopathic urinary retention.
From: Treatment of the Postmenopausal Woman (Third Edition), 2007
Feces IncontinenceBladderSphincterMicturitionOveractive Bladder
MAT H. HO, NARENDER N. BHATIA, in Treatment of the Postmenopausal Woman (Third Edition), 2007
b Sacral Neuromodulation
Sacral neuromodulation is a long-term electrical stimulation of the S3 nerve root that has been approved by the FDA for the treatment of IDO, frequency-urgency syndrome, and idiopathic urinary retention. The mechanism of action of sacral neuromodulation in the treatment of IC is unclear, although this modality has been applied to a small number of patients who failed other modes of treatment, with promising results (94,149). Thus far, it has significantly reduced urinary frequency and urgency symptoms as well as the pain associated with IC. Recently, a multicenter clinical trial also showed significant improvements in urinary frequency, pain symptoms, and voided volumes (150). The neuromodulation is achieved with an implanted lead that is placed through S3 foramen and an implanted electrical pulse generator as described in detail elsewhere (94).
When I hear on THE NETWORK that those NOT WINNING-----AKA----'THEM' are the only ones attached to this ILLEGAL, UNCONSENTING, UNKNOWING medical research---and that 'US' will benefit and not have it used as MEDICAL WEAPON-----
WE NEED OUR 5% FREEMASON/GREEK PLAYERS/POLS TO WAKE UP========AND LEAVE ALL THAT VIRTUAL REALITY BEHIND.
Clinical & Quality Management
MEDICAL POLICYCopyright 2014, Proprietary Information of UCare Page. 1of 14
Sacral Nerve Stimulation For Urinary Voiding Dysfunction and Fecal Incontinence
Policy Number: 2014M0065A
Effective Date:September1, 2014
Table of Contents: Page: Cross Reference Policy:POLICY DESCRIPTION2
Pelvic Floor Electrical Stimulation for the Treatment of Urinary Incontinence, 2013
Extracorporeal Magnetic Stimulation For Urinary Incontinence, 2013M0016A
COVERAGE RATIONALE/CLINICAL CONSIDERATIONS2BACKGROUND4REGULATORY STATUS5CLINICAL EVIDENCE7 APPLICABLE CODES7 REFERENCES9 POLICY HISTORY/REVISION
INSTRUCTIONS: “Medical Policy assists in administering UCare benefits when making coverage determinations for members under our health benefit plans. When deciding coverage, all reviewers must first identify enrollee eligibility, federal and state legislation or regulatory guidance regarding benefit mandates, and the member specific Evidence of Coverage (EOC) document must be referenced prior to using the medical policies. In the event of a conflict, the enrollee's specific benefit document and federal and state legislation and regulatory guidance supersede this Medical Policy. In the absence of benefit mandates or regulatory guidance that govern the service, procedure or treatment, or when the member’s EOC document is silent or not specific, medical policies help to clarify which healthcare services may or may not be covered. This Medical Policy is provided for informational purposes and does not constitute medical advice. In addition to medical policies, UCare also uses tools developed by third parties, such as the InterQual Guidelines®, to assist us in administering health benefits. The InterQual Guidelines are intended to be used in connection with the independent professional medical judgment of a qualified health care provider and do not constitute the practice of medicine or medical advice.
Other Policies and Coverage Determination Guidelines may also apply. UCare reserves the right, in its sole discretion, to modify its Policies and Guidelines as necessary and to provide benefits otherwise excluded by medical policies when necessitated by operational considerations.”
Clinical & Quality Management
MEDICAL POLICYCopyright 2014, Proprietary Information of UCare Page. 3of 141.
All of the criteria in A (1-4) above are met.2.
A trial stimulation period demonstrates at least 50% improvement in symptoms over a period of at least 1 week.C.Other urinary/voiding applications of sacral nerve neuromodulation are considered INVESTIGATIONAL AND/OR EXPERIMENTAL, including but not limited to treatment of stress incontinence or urge incontinence due to a neurologic condition, e.g., detrusor hyperreflexia, multiple sclerosis, spinal cord injury, or other types of chronic voiding dysfunction.II.
A trial period of sacral nerve neuromodulation with either percutaneous nerve stimulation or a temporarily implanted lead may be considered MEDICALLY NECESSARY in patients who meet all of the following criteria: 1.There is a diagnosis of chronic fecal incontinence of greater than 2 incontinent episodes on average per week with duration greater than 6 months or for more than 12 months after vaginal childbirth.2.There is documented failure, contraindication, or intolerance to conventional conservative therapy (e.g., dietary modification, the addition of bulking and pharmacologic treatment for at least a sufficient duration to fully assess its efficacy, performed more than 12 months. 3.Sphincter surgery is either not indicated or is contraindicated4.Absence of a significant anorectal malformation (e.g., congenital anorectal malformation; defects of the external anal sphincter over 60 degrees; visible sequelae of pelvic radiation; active anal abscesses and fistulae) or chronic inflammatory bowel disease involving the anus. 5.Incontinence is not secondary to another neurologic condition such as peripheral neuropathy or complete spinal cord injury.B.Permanent implantation of a sacral nerve neuromodulation device may be considered medically necessary in patients who meet all of the following criteria: 1.All of the criteria in II- A (1-5) above are met.
2.A trial stimulation period demonstrates at least 50% sustained improvement in symptoms over a period of at least 1 week.C.Sacral nerve neuromodulation is considered INVESTIGATIONAL AND/OR EXPERIMENTAL in the treatment of chronic constipation or chronic pelvic pain.D.Sacral nerve neuromodulation is consideredINVESTIGATIONAL AND/OR EXPERIMENTAL in the treatment of fecal incontinence in children. There is insufficient evidence to recommend the widespread clinical adoption of the InterStim Therapy System for pediatric patients less than 18 years of age with fecal incontinence due to the lack of evidence regarding its safety and clinical value.
Clinical Considerations:Prior to the implantation of a permanent SNS system, patients are screened for potential therapeutic
This policy provides information on sacral nerve neuromodulation (SNM) treatment, also known as sacral nerve stimulation (SNS), an alternative treatment modality for patients with fecal or urinary incontinence(UI) who have failed behavioral and/or pharmacologic therapies. The SNM device (Medtronic InterStim® Sacral Nerve Stimulation system) consists of an implantable pulse generator that delivers controlled electrical impulses.
This pulse generator (implanted in the abdomen) is attached to wire leads (tunneled below the skin) that connect to the sacral nerves, most commonly the S3 nerve root. Two external components of the system help control the electrical stimulation. A control magnet is kept by the patient and can be used to turn the device on or off. A console programmer is kept by the physician and used to adjust the settings of the pulse generator.This therapy consists of two phases, the test stimulation phase and implantation.
The goal of sacral nerve neuromodulation treatment is to restore voluntary urination/defecation in patients with urinary or fecal voiding dysfunction. This policy does not address pelvic floor stimulation. For pelvic floor stimulation information refer to the medical policy “Pelvic Floor Electrical Stimulation for the Treatment of UI”, 2013M0028A.
COVERAGE RATIONALE / CLINICAL CONSIDERATIONS:
I.Urinary Incontinence (UI) and Non-obstructive RetentionA.
A trial period of sacral nerve neuromodulation with either percutaneous nerve stimulation or a temporarily implanted lead may be considered MEDICALLY NECESSARY in patients who meet all of the following criteria: 1.There is a diagnosis of at least one of the following:
a.Urinary urge incontinence
b.Urinary urgency-frequency syndromec.
c.Non-obstructive urinary retention
2.The patient has experienced urge UI or symptoms of urge-frequency for at least 12 months and the condition has resulted in significant disability (the frequency and/or severity of symptoms are limiting the member's ability to participate in daily activities)
3.There is documented failure or intolerance to at least two conventional conservative therapies:
a.Behavioral training such as bladder training or biofeedback
c.Pelvic muscle exercise training (e.g., kegel exercises)
d.Pharmacologic treatment for at least a sufficient duration to fully assess its efficacy, and/or surgical corrective therapy
4.The patient is an appropriate surgical candidate.
5.Incontinence is not related to a neurologic condition.
B.Permanent implantation of a sacral nerve neuromodulation device may be considered medically necessary in patients who meet all of the following criteria:
Clinical & Quality Management
Copyright 2014, Proprietary Information of UCare Page. 4of 14
benefit by undergoing a trial in which a temporary electrode is percutaneously introduced into the left or right sacral nerve foramen and an external device provides continuous stimulation.
The length of the screening trial varies. The patient must demonstrate a positive therapeutic response to qualify as a candidate for permanent implantation. Complications/Adverse Events: •Device-related pain, discomfort, and/or infection at the implantation site. •Technical complications such as early displacement of the electrode (also called lead migration) that required repositioning and revision of the permanent electrode due to functional failure.
Contraindications: •According to the manufacturer, the safety and effectiveness of the InterStim Therapy system has not been established for bilateral stimulation; use during pregnancy and delivery; on an unborn fetus; pediatric use under the age of 18 years; or for patients with progressive, systemic neurological diseases.•The InterStim Therapy System should not be used in patients who are undergoing any type of diathermy, a heat treatment used for sore or stiff muscles, including shortwave, microwave, or therapeutic ultrasound diathermy. •The procedure is not recommended in patients with recent rectal surgery; external rectal prolapsed, chronic bowel disease; or in patients with urologic or gynecologic malignancies. •InterStim Therapy System may be affected by or adversely affect cardiac devices, electrocautery, defibrillators, ultrasonic equipment, radiation therapy, magnetic resonance imaging, theft detectors, or screening devices.
Urinary voiding dysfunction, also referred to as urinary incontinence (UI), is generally defined as the inability to control urination. The prevalence of UI for men and women between the ages of 15 and 64 years has been reported to be 25% to 55%, although it approaches approximately 60% among nursing home residents of both sexes. Several studies report that women are affected twice as often as men younger than 80 years of age, and after 80 years of age, the prevalence rate is similar. Urinary voiding disorders are generally divided into five types of incontinence, depending on the pathophysiology involved: ur ge, overflow, stress, mixed, and functional. In urge incontinence, urine leakage results from the inability to inhibit the voiding reflex consciously.
A subtype of this condition, urgency-frequency syndrome, is characterized by uncontrollable urgency without urine loss and the need to void more than 7 times per day. Overflow incontinence, or urinary retention, is a condition in which the bladder overfills without causing the sensation of the need to urinate. Stress incontinence is characterized by the leakage of urine during physical activities that increase pressure on the bladder. Mixed incontinence refers to a combination of urge and stress incontinence. Functional incontinence refers to the inability of a person to reach the bathroom due to chronic impairment of physical or mental functioning.
Treatment options for urinary voiding disorders include behavioral strategies, pharmacological interventions, temporary electrical stimulation, and reconstructive surgery. Usually, the less invasive first-tier behavioral and pharmacological interventions are advised and are often combined with temporary electrical stimulation before irreversible, reconstructive surgery is considered as a treatment choice
3.MINNESOTA DEPARTMENT OF HUMAN SERVICES (DHS):Incontinence Treatment Systems
Clinical & Quality Management
MEDICAL POLICYCopyright 2014, Proprietary Information of UCare Page. 5of 14
Fecal incontinence is the inability to control the release of fecal matter, which can cause significant embarrassment, social isolation, and reduced quality of life (QOL). The overall prevalence of fecal incontinence ranges from 1% to 7% in otherwise healthy individuals, and up to 10% in the elderly.
The prevalence of fecal incontinence is disproportionally higher in women, in the elderly, and in nursing home residents. There are many causes of fecal incontinence including anal sphincter trauma, local rectal pathology, neurological disorders, congenital anomalies, psychological chronic soiling, and the normal aging process. There are several conservative and surgical options for fecal incontinence. First-line treatments generally include nonsurgical approaches, such as biofeedback therapy, use of absorbent products, lifestyle and dietary modifications, bowel habit interventions, anal plugs, pelvic floor muscle training, rectal irrigation, and drug therapy. If first-line treatment fails, surgical management generally includes repair of the anal sphincter, use of injectible bulking agents, development of an artificial bowel sphincter, stoma, antegrade continence edema, and percutaneous tibial nerve stimulation.
When the BLADDER IMPLANT was installed in 2010 I had NO bladder or bowel problems------I was able to go all day without rushing to the bathroom. After this implant and all the MANIPULATIONS of urinary and bowel I may indeed have a problem with a weakened BLADDER SPHINCTER. The continous manipulation by these IMPLANTS do harm natural body functions. No noticable damage to bowel.
'Bladder Dysfunction and Urine Control in Children ...www.urologyhealth.org/urologic-conditions/bladder-dysfunction-and-urine... These reasons link both problems: The rectum is behind the bladder. When there is a large amount of stool in the rectum, it can push on the bladder. The pelvic floor muscles control both the bladder sphincter and anal sphincter. Children who feel pain when they have a bowel movement will tend...'
REMEMBER, all of these BARBER SURGEON implant studies are HITTING both MEN AND WOMEN. I represent what WOMEN are facing-----MALE GONAD----MALE URETHRA -----with implants are creating the same HARM. For men PROSTATE is part of this damage. Men having PROSTATE CANCER should think if they have these SACRAL NERVE IMPLANTS----these BLADDER/BOWEL IMPLANTS and know these will harm surrounding organ systems ---
SEX AND DIGESTIVE.
Principles of Gender-Specific Medicine (Second Edition)
2010, Pages 318-325
Principles of Gender-Specific Medicine
Chapter 29 - Disorders of Defecation in Women
Author links open overlay panel
Assistant Professor of Colorectal Surgery, Johns Hopkins Medical Institutions, Baltimore, MD, USA
Available online 17 March 2010.
Pelvic floor disorders are known to effect up to 42% of adult women. These disorders include urinary incontinence, fecal incontinence, pelvic organ prolapse, and obstructed defecation. Risk factors include increasing age, increasing parity, and more recently, obesity. It is estimated that by 2030 more than one-fifth of the US female population will be over 65 years of age. As the age of this population increases, the national burden of healthcare costs, lost productivity, and decreased quality of life will be substantial. This chapter discusses the more common disorders of defecation, including constipation and fecal incontinence. It describes the etiology of constipation, and its evaluation and various treatment methods. The initial evaluation of a patient presenting with either longstanding or new-onset constipation is a detailed history. Current medical conditions and prescribed and over-the-counter medication use should be reviewed.
Information regarding bowel habits at a young age may provide useful information into causation. Furthermore, a careful physical exam particularly of the anorectum, is essential to rule out any anorectal disorders that may exacerbate the patient's symptoms. Digital exam should be performed while having the patient squeeze the anal sphincter muscles, relax, and then attempt to evacuate. All patients, and especially those who are of the age of 50 years or have had a recent change in bowel habits, need to be evaluated with colonoscopy as part of the initial work-up of constipation. The chapter describes the treatment of constipation related to pelvic floor dysfunction and slow transit.
My jaw and continuously inflamed gums and tooth root pain have gone since NOSE IMPLANT created all these painful symptoms. The BARBER SURGEON dentists being HOSTING SERVER NOSY NEIGHBORS no doubt using this to make people's teeth fall out----ergo DENTAL IMPLANTS. I know this is why HOSTING SERVER wants me KNOCKED OUT to be updated.
Sorry, all my TEETH and my GUMS have healed---and are fine.
DON'T WORRY SAYS HOSTING SERVER NOSY NEIGHBORS-----WE HAVE SOMETHING TO REPLACE THE OLFACTORY BULB DESTROYED BY THESE SINUS IMPLANTS!
How many people have OLFACTORY disorders? What each of these studies did was create a PATENTED PRODUCT which then was then used to generate a billion dollar industry. The SMELLS AND TASTE as we said early largely tied to FAKE FOOD ------and SPACE COLONIZATION needs.
An exception to the rule: An intact sense of smell without a crucial olfactory brain structure
November 11, 2019
Weizmann Institute of Science
A handful of left-handed women have excellent senses of smell, despite lacking olfactory bulbs.
Is a pair of brain structures called the olfactory bulbs, which are said to encode our sense of smell, necessary? That is, are they essential to the existence of this sense? Weizmann Institute of Science researchers recently showed that some humans can smell just fine, thank you, without olfactory bulbs. Their finding -- that around 0.6% of women, and more specifically, up to 4% of left-handed women, have completely intact senses of smell despite having no olfactory bulbs in their brains -- calls into question the accepted notion that this structure is absolutely necessary for the act of smelling. The findings of this research, which were published today in Neuron, may shake up certain conventional theories that describe the workings of our sense of smell.
In the majority of people who have functioning olfactory bulbs, nerve signals from receptors in the nose go first through the bulbs before being passed onwards toward the olfactory center in the cortex. The prevailing theory has the olfactory bulbs combining the information from the six million receptors in our noses, of some 400 different types, and encoding a unique "odor" signal to be passed on. Thus, unsurprisingly, some people who are congenitally anosmic -- that is, they never had a sense of smell -- indeed have no olfactory bulbs.
THIS IS WHAT THOSE NOSE/SINUS IMPLANTS ARE DESTROYING-----6 MILLION RECEPTORS---
Although the centrality of the olfactory bulbs in olfactory perception is the "textbook" view, in the 1980s and 1990s some researchers had removed the olfactory bulbs from the brains of rodents and found their sense of smell to remain functional. These findings, however, were not well received in the scientific community.
The new findings were unexpected:
Drs. Tali Weiss and Sagit Shushan in the lab of Prof. Noam Sobel of the Institute's Neurobiology Department were conducting MRI scans of subject's brains in the Azrieli National Institute for Human Brain Imaging and Research on campus. One of the subjects, who had stated her sense of smell was normal, was found to be lacking olfactory bulbs in her brain. The subject insisted: Her sense of smell was not only normal, it was excellent. "We tested her smelling faculties in every way would could think of, and she was right," says Sobel. "Her sense of smell was indeed above average. And she really doesn't have olfactory bulbs. We conducted another scan with especially high-resolution imaging, and saw no signs of this structure."
How do these "exceptions to the rule" square with the commonly held view of the sense of smell? There are several possible explanations. One is that the highly plastic brain creates a "smell map" in a different part of these women's brains. But another possible explanation is that these exceptions do disprove the rule. "Current ideas posit the olfactory bulb as a 'processing center' for information that is complex and multi-dimensional, but it may be that our sense of smell works on a simpler principle, with fewer dimensions. It will take high resolution imaging -- higher than that approved for use on humans today -- to resolve that issue," says Sobel. "But the fact remains that these women smell the world in the same way as the rest of us, and we don't know how they achieve this."
WE DO NOT NEED GMO HUMANS AS SPACE COLONY MINING SLAVES-----global banking 1% has the ability to use ROBOTS AS MINERS----as we see in these articles. Whether UNDERSEA or on EARTH'S surface -----ROBOTS CAN AND MUST be those PLANETARY MINING SLAVES----not our US 99% WE THE PEOPLE or new to US global labor pool.
The research driven by TELEMEDICINE tied to GLOBAL MILITARY corporations working for OLD WORLD KINGS KNIGHTS OF MALTA TRIBE OF JUDAH------has nothing to do with attaining these SPACE GOALS----the goals are only POWER AND CONTROL OF 'THEM' ----NOT 'US'----'US' being those global .00014% of people.
There is NO HUMAN BENEFIT MOVING FORWARD with CLINTON/BUSH/OBAMA ------AFFORDABLE CARE ACT-----fake evidence-based medicine-----leading to control human body control via TELEMEDICINE.
Our global banking 5% freemason/Greek players sold on MOVING FORWARD SPACE COLONIZATION are being DUPED if they think GMO HUMANS are needed for these planetary mining goals. Those HUMANS seeing themselves as a CAPTAIN KIRK------are few and far between while this BODY IMPLANT TECHNOLOGY is KILLING NATURAL HUMANS and creating MIND/BODY CONTROL ---DEEP DEEP REALLY STATE.
This photo by FORBES of a global banking 2% player makes me think -----this man is BRAIN IMPLANTED-----they are messing his mind.
These SPACE TRIPS to MARS et al will be DEADLY for any human possibly forever---please don't line up to be a GMO HUMAN.
These Are The Robots That Will Mine In Hell
Jon Markman Senior Contributor
Analyzing tech stocks through the prism of cultural change.
This article is more than 2 years old.
Mining giant Rio Tinto PLC is willing to go to hell and back for copper.
Its new mine near Superior, Arizona, bores nearly 7,000 feet below the Earth’s surface. There, temperatures routinely hit 175 degrees Fahrenheit. Warm water falls from overhead rocks like rain.
The 1.3-mile-deep shaft is being excavated by Resolution Copper Mining, a subsidiary of London-based Rio Tinto and Australia-based BHP Billiton Ltd.
The Wall Street Journal reports, it’s a project no sane executive would have green-lighted a decade ago. The technical challenges are that daunting. The attraction is the opportunity to change the business of mining with more sensors, autonomous vehicles and data analytics than ever before.
It wouldn’t be the first time technology changed the landscape of the natural resources industry. Just as data analytics and advanced modeling made it easier to fracture shale and find natural gas, these tools will figure prominently at Resolution.
After engineers figure out how to deal with the heat and the water, they plan to completely reimagine mining. Caterpillar Inc. and Komatsu Mining Corp. are already building custom electric loaders, excavators and other robotic gear. They will be equipped with thousands of sensors to achieve full automation.
The machines will find the ore, mine it and transport it to the surface under the watchful eye of technicians hundreds of miles away.
None of this has come cheap. The Wall Street Journal reports the project will cost at least $6 billion. And operation is not scheduled to begin until the mid-2020s, thanks to the regulatory process.
However, the payoff is potentially huge. The mining industry has exhausted the supply of easy-to-find, high-grade copper ore available at open pit mines. Copper deposits exist, but they are hard to get at.
The Resolution mine may have 1.6 billion tons of ore, and a 40-year productive life. However, because the development will lean heavily on automation, costs are expected to be on par with open pit sites.
And future prices are expected to be strong.
That’s because copper plays an outsized role in electric vehicles. EVs represent a tiny fraction of all vehicles sold today but their numbers are growing quickly.
BHP, a minority partner in the Resolution project, expects there will be 140 million EVs on the road by 2035. Today, there are 1 million. The Financial Times reports EVs use roughly four-times as much copper as internal combustion cars.
If BHP is right, and EVs displace 8% of traditional vehicles by 2035, the math works out to 8.5 million tons of new demand. That is about one-third of the total current demand. You can imagine what that imbalance would do to copper prices.
More importantly, think about the new business models possible. Think about the opportunities available to astute investors willing to look into the future.
I believe we are living through an age of invention unrivaled since the Gilded Age. Increased computing power, robotics and sensors allowed Rio Tinto executives to dream about mining copper more than a mile below the Earth’s surface.
Data analytics will allow the mine to operate as cost effectively as a traditional open pit. Likely productivity gains from digitalization are not yet reflected in share prices. I am mapping out the winners and losers from these developments and will have a recommendation soon.